Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |